ArticleOpen forum infectious diseases2024

Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273.

Veronica Urdaneta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.